Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

SCM Pharma

SCM Pharma is a contract development & manufacturing organisation (CDMO) that develops and makes novel, difficult and dangerous drugs on behalf of our clients. Our formulation development, cGMP manufacturing and aseptic processing services include the sterile filling of liquids, gels and powders (including flammable products) into a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles. So if you’re a pharmaceutical, biotech, medical device or healthcare institution in need of formulation development, clinical manufacturing or contract filling involving a complex product or process – let’s talk.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

SCM Pharma
Unit 6 Regents Drive, Low Prudhoe Industrial Estate, Prudhoe, Northumberland, NE42 6PX, United Kingdom
+44(0) 1661 833 693
Contact SCM Pharma
Website

 Latest Content from PMHub 

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Press Releases | December 23, 2025 | Medscape Education

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

Press Releases | December 23, 2025 | Medscape Education

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

Press Releases | December 23, 2025 | Medscape Education

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Press Releases | December 23, 2025 | Medscape Education

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Press Releases | December 23, 2025 | Medscape Education

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

Videos and Podcasts | December 19, 2025 | Graphite Digital

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Redefining digital ROI: Engagement, experience, and the new metrics of success

Videos and Podcasts | December 18, 2025 | Graphite Digital

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

What will healthcare communications look like in 2026? Amiculum’s prediction of upcoming trends

White Papers and Resources | December 16, 2025 | Amiculum

By Sarah Theobald

Clinical research in 2026: The trends shaping tomorrow

White Papers and Resources | December 16, 2025 | Cuttsy + Cuttsy

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

Lack of education causes patients to stop vital treatments, survey finds

Press Releases | December 15, 2025 | Healthinote (by Cognitant)

Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit from prescribed treatments. Nearly 80% of healthcare professionals identify...